Rheumatology Advance Access originally published online on February 28, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2003; 42: 553-562
© 2003 British Society for Rheumatology
Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis
Department of Medicine IV, University of Leipzig, Leipzig,
1 Institute for Clinical Immunology, Department of Medicine III, University of Erlangen-Nürnberg, Erlangen and
2 Institute for Transplantation Diagnostics and Cell Therapeutics, Düsseldorf University Medical Center, Düsseldorf, Germany
Objective. To evaluate the differential impact of HLA-DR and -DQ on the progression of erosive disease in the clinical course of early rheumatoid arthritis (RA).
Methods. HLA genotyping for HLA-DR and -DQ was carried out in a prospective study of 87 patients with early RA. The progression of erosive disease was assessed by radiological scores over a period of 2 yr in all patients and over 4 yr in 77 patients. The impact of HLA markers was evaluated by univariate comparisons and by multiple logistic regression analyses.
Results. Patients expressing the RA-associated shared epitope (SE) on a DRB1*01-positive or, most prominently, on a DRB1*04-positive allele had higher Larsen scores at all time-points analysed when compared with SE-negative patients. A similar impact on radiological progression was seen for the RA-predisposing DQ3, but not for DQ5 heterodimers. In the presence or absence of the DRB1 SE, no additional effects could be discerned for RA-associated DQ molecules. The presence of a DERAA-positive DRB1 allele was associated with a slower pace of joint destruction. While gene dosage effects were seen for SE compound homozygosity, no effect for DQ3 homozygosity could be discerned.
Conclusion. Although a significant influence of HLA-DQ3 heterodimers on the progression of erosive joint destruction was seen, the analysis of the HLA-DQ locus did not add additional information over the study of HLA-DR including the determination of the SE and the DERAA motif in order to predict the development of severe progressive joint destruction.
KEY WORDS: Rheumatoid arthritis, Joint destruction, Immunogenetics, Human leucocyte antigens (HLA), Epidemiology.
Correspondence to: R. Wassmuth, Institute for Transplantation Diagnostics and Cell Therapeutics, University Medical Center, University of Düsseldorf, Moorenstrasse 5, Building 14.80, D-40225 Düsseldorf, Germany. E-mail: ralf.wassmuth{at}itz.uni-duesseldorf.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Kaltenhauser, M. Pierer, S. Arnold, M. Kamprad, C. Baerwald, H. Hantzschel, and U. Wagner Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis Rheumatology, January 1, 2007; 46(1): 100 - 104. [Abstract] [Full Text] [PDF]
|
|